Serum Institute of India gets regulatory approval to resume Indian trial of AstraZeneca COVID vaccine.

Global Banking News-September 16, 2020-Serum Institute of India gets regulatory approval to resume Indian trial of AstraZeneca COVID vaccine

(C)2020 ENPublishing - http://www.enpublishing.co.uk

Reuters news agency reported on Wednesday that according to a source, Serum Institute of India has received Indian regulatory approval, from the Drugs Controller General of India, to resume local clinical trials of British pharmaceutical company AstraZeneca's potential COVID-19 vaccine.

Reportedly, AstraZeneca has resumed British clinical trials of the vaccine, considered one of the most advanced in development for...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT